Literature DB >> 8381965

Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.

M J Coppes1, G J Liefers, P Paul, H Yeger, B R Williams.   

Abstract

Wilms tumor may be caused by loss of function of genes at different loci. A Wilms tumor suppressor gene, WT1, at chromosome 11 band p13, has recently been cloned and characterized. WT1 has been implicated in the development of Wilms tumor by virtue of mutations in patients with genitourinary anomalies and susceptibility to Wilms tumor. Homozygous intragenic mutations have been reported in Wilms tumors, but usually not in sporadic unilateral Wilms tumors, which constitute the majority of Wilms tumor cases. Using the single-strand conformational polymorphism assay, we have identified three sporadic unilateral Wilms tumors with homozygous point mutations: one with a de novo germ-line nonsense point mutation within WT1 exon 8, and two carrying a somatic mutation within WT1 exon 10. In all three cases loss of the wild-type allele was demonstrated by tumor loss of heterozygosity. This report provides an example of two somatic mutations in the same tumor expected to inactivate WT1 function.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381965      PMCID: PMC45884          DOI: 10.1073/pnas.90.4.1416

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  The essentials of DNA methylation.

Authors:  A Bird
Journal:  Cell       Date:  1992-07-10       Impact factor: 41.582

2.  Detection of heterozygous mutations in the RB1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing.

Authors:  A Hogg; Z Onadim; P N Baird; J K Cowell
Journal:  Oncogene       Date:  1992-07       Impact factor: 9.867

3.  Coordinate expression of Wilms' tumor genes correlates with Wilms' tumor phenotypes.

Authors:  H Yeger; C Cullinane; A Flenniken; S Chilton-MacNeil; C Campbell; A Huang; L Bonetta; M J Coppes; P Thorner; B R Williams
Journal:  Cell Growth Differ       Date:  1992-12

4.  Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.

Authors:  P N Baird; A Santos; N Groves; L Jadresic; J K Cowell
Journal:  Hum Mol Genet       Date:  1992-08       Impact factor: 6.150

5.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

Authors:  J Pelletier; W Bruening; F P Li; D A Haber; T Glaser; D E Housman
Journal:  Nature       Date:  1991-10-03       Impact factor: 49.962

6.  A tumor chromosome rearrangement further defines the 11p13 Wilms tumor locus.

Authors:  L M Davis; B Zabel; G Senger; H J Lüdecke; B Metzroth; K Call; D Housman; U Claussen; B Horsthemke; T B Shows
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

Review 7.  Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.

Authors:  M J Coppes; L Bonetta; A Huang; P Hoban; S Chilton-MacNeill; C E Campbell; R Weksberg; H Yeger; A E Reeve; B R Williams
Journal:  Genes Chromosomes Cancer       Date:  1992-11       Impact factor: 5.006

8.  Inherited WT1 mutation in Denys-Drash syndrome.

Authors:  M J Coppes; G J Liefers; M Higuchi; A B Zinn; J W Balfe; B R Williams
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

9.  Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development.

Authors:  W Bruening; N Bardeesy; B L Silverman; R A Cohn; G A Machin; A J Aronson; D Housman; J Pelletier
Journal:  Nat Genet       Date:  1992-05       Impact factor: 38.330

10.  Zinc finger point mutations within the WT1 gene in Wilms tumor patients.

Authors:  M H Little; J Prosser; A Condie; P J Smith; V Van Heyningen; N D Hastie
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

View more
  14 in total

1.  Somatic deletion of the 5' ends of both the COL4A5 and COL4A6 genes in a sporadic leiomyoma of the esophagus.

Authors:  L Heidet; E Boye; Y Cai; Y Sado; X Zhang; J F Fléjou; F Fékété; Y Ninomiya; M C Gubler; C Antignac
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

2.  Antagonism of WT1 activity by protein self-association.

Authors:  P Moffett; W Bruening; H Nakagama; N Bardeesy; D Housman; D E Housman; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

3.  DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1.

Authors:  I A Drummond; H D Rupprecht; P Rohwer-Nutter; J M Lopez-Guisa; S L Madden; F J Rauscher; V P Sukhatme
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

4.  Overlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product.

Authors:  N Bardeesy; J Pelletier
Journal:  Nucleic Acids Res       Date:  1998-04-01       Impact factor: 16.971

5.  PAX8-mediated activation of the wt1 tumor suppressor gene.

Authors:  M Dehbi; J Pelletier
Journal:  EMBO J       Date:  1996-08-15       Impact factor: 11.598

6.  Software and database for the analysis of mutations in the human WT1 gene.

Authors:  C Jeanpierre; C Béroud; P Niaudet; C Junien
Journal:  Nucleic Acids Res       Date:  1998-01-01       Impact factor: 16.971

7.  novH: differential expression in developing kidney and Wilm's tumors.

Authors:  G Chevalier; H Yeger; C Martinerie; M Laurent; J Alami; P N Schofield; B Perbal
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

8.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 9.  The role of WT1 in oncogenesis: tumor suppressor or oncogene?

Authors:  David M Loeb; Saraswati Sukumar
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

10.  Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.

Authors:  H Nakagama; G Heinrich; J Pelletier; D E Housman
Journal:  Mol Cell Biol       Date:  1995-03       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.